Latest News in the pharma Industry

Top Stories

Report recommends patient-centric approach to encourage adherence

Report recommends patient-centric approach to encourage adherence

5 Nov 2012

Patient adherence to medication could be improved by adopting a more patient-centric approach, a report suggests.

Read more 
UK spending on new medicines is falling

UK spending on new medicines is falling

5 Nov 2012

The head of the ABPI has expressed concern at the UK's falling expenditure on new medicines.

Read more 
Watson sells Rugby OTC products and trademarks to Major Pharmaceuticals

Watson sells Rugby OTC products and trademarks to Major Pharmaceuticals

30 Oct 2012

Watson has sold its Rugby OTC product trademark and assets to the Harvard Drug Group.

Read more 
Bayer set to buy Schiff Nutrition International for $1.2bn

Bayer set to buy Schiff Nutrition International for $1.2bn

30 Oct 2012

Bayer has struck a deal to acquire US vitamin maker Schiff.

Read more 
BioRx receives Zemaira distribution rights

BioRx receives Zemaira distribution rights

30 Oct 2012

BioRx has been added to the distribution network for Zemaira.

Read more 
Celgene reports $1.4 billion of revenues for third quarter 2012

Celgene reports $1.4 billion of revenues for third quarter 2012

26 Oct 2012

Celgene enjoyed healthy profits in the third quarter of 2012

Read more 
Sanofi to continue developing Prednisporin under sub-licencing agreement

Sanofi to continue developing Prednisporin under sub-licencing agreement

26 Oct 2012

Sanofi will continue development of Prednisporin, but expects to sub-licence the work to a third-party.

Read more 
Organisational structure 'key to pharma compliance'

Organisational structure 'key to pharma compliance'

26 Oct 2012

Pharmaceuticals have been told to centralise their compliance efforts for greater success.

Read more 
Report reveals downward trend in US health R&D investment

Report reveals downward trend in US health R&D investment

26 Oct 2012

There are concerns that the downward trend in R&D investment in the US could jeopardise the country's global competitiveness.

Read more 
Charles River enters strategic partnership with AstraZeneca

Charles River enters strategic partnership with AstraZeneca

25 Oct 2012

Charles River Laboratories and AstraZeneca have reached a three-year agreement to deliver toxicology, safety pharmacology and development DMPK studies.

Read more 
Forest and moksha8 form broad strategic alliance for Latin America

Forest and moksha8 form broad strategic alliance for Latin America

25 Oct 2012

Forest Laboratories and moksha8 have announced a broad strategic alliance for Latin America.

Read more 
Medicated chewing gum may prevent motion sickness

Medicated chewing gum may prevent motion sickness

22 Oct 2012

A team in Iran have produced a prototype gum with an acceptable taste that could help to deliver the motion sickness drug dimenhydrinate more rapidly.

Read more